FK506E (MR4)

· Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FK506E (MR4), covering 2014-07-09 to 2014-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation [Phase 3]

See pricing